Brucine-loaded liposomes composed of HSPC and DPPC at different ratios: in vitro and in vivo evaluation

Abstract

Objective: The objective of this study is to test the hypothesis that the phase transition temperature (T_m), the main property of liposomes, can be easily controlled by changing the molar ratio of hydrogenated soy phosphatidylcholine (HSPC) and 1,2-dipalmitoyl-sn-glycero-3-phosphacholine (DPPC) after drug encapsulation.

Materials and methods: Brucine, an antitumor alkaloid, was encapsulated into the liposomes with different HSPC/DPPC compositions. The T_ms of the brucine-loaded liposomes (BLs) were determined by differential scanning calorimetry (DSC). Then the physicochemical properties and pharmacokinetics of the BLs with different HSPC/DPPC compositions were investigated and compared.

Results: The results of DSC revealed that HSPC and DPPC can combine into one phase. The findings of molecular modeling study suggested that HSPC interacts with DPPC via electrostatic interaction. The molar ratio of HSPC/DPPC influenced the sizes of BLs but had little effect on the entrapment efficiency (EE). The stability of BLs was improved with the increase of the HSPC ratios, especially with the presence of plasma. Following i.v. administration, it was found that AUC values of BLs in vivo were directly related to the HSPC/DPPC ratios of BLs, namely the T_ms of BLs.

Discussion: The behavior of liposomes, especially in vivo pharmacokinetic behavior, can be controlled by the modification of T_m.

Conclusion: The characterization of BLs in vitro and in vivo had demonstrated that the T_m could be flexibly modified for liposomes composed of both HSPC and DPPC. Using HSPC/DPPC composition may be an efficient strategy to control the T_m, thus control the in vivo pharmacokinetic behavio, of BLs.

• Brucine
• liposomes
• molecular modeling
• pharmacokinetics
• phase transition temperature
• phosphatidylcholine